Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001628280-25-033150

Options or other derivatives

  • Director acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
YU Wing Tak Wendy Director 2025-06-24 Grant or award · Stock Option (right to buy) +20,000 20,000 D
Loading xslF345X05/wk-form4_1750973437.xml…